Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F21%3A00124332" target="_blank" >RIV/00216224:14110/21:00124332 - isvavai.cz</a>
Result on the web
<a href="https://www.medrxiv.org/content/10.1101/2021.01.08.20248149v1.full.pdf" target="_blank" >https://www.medrxiv.org/content/10.1101/2021.01.08.20248149v1.full.pdf</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1101/2021.01.08.20248149" target="_blank" >10.1101/2021.01.08.20248149</a>
Alternative languages
Result language
angličtina
Original language name
Antiviral drugs in hospitalized patients with COVID-19 - the DisCoVeRy trial
Original language description
Background Lopinavir/ritonavir, lopinavir/ritonavir-interferon (IFN)-β-1a and hydroxychloroquine efficacy for COVID-19 have been evaluated, but detailed evaluation is lacking. Objective To determine the efficacy of lopinavir/ritonavir, lopinavir/ritonavir-IFN-β-1a, hydroxychloroquine or remdesivir for improving the clinical, virological outcomes in COVID-19 inpatients. Design Open-label, randomized, adaptive, controlled trial.
Czech name
—
Czech description
—
Classification
Type
J<sub>ost</sub> - Miscellaneous article in a specialist periodical
CEP classification
—
OECD FORD branch
30230 - Other clinical medicine subjects
Result continuities
Project
—
Continuities
—
Others
Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
medRxiv 20218149 [Preprint]
ISSN
1756-1833
e-ISSN
1756-1833
Volume of the periodical
2021
Issue of the periodical within the volume
1
Country of publishing house
GB - UNITED KINGDOM
Number of pages
31
Pages from-to
1-31
UT code for WoS article
—
EID of the result in the Scopus database
—